Stock listing
NASDAQ:HARP Harpoon Therapeutics Inc Stock
Follow Harpoon Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:HARP
$23.01 USD
Close on Mar 11, 2024 · No longer trades
- Lowest – highest close
- $3.29 – $23.01 USDSince Sep 5, 2023 · lowest Oct 10, 2023 · highest Mar 8, 2024
Delisted NASDAQ:HARP no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:HARP
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Harpoon Therapeutics Inc on 6ix
- Decks
- 8 decks · latest Jan 26, 2024
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Technical Presentation (January 2024) | Technical | 12 slides | Jan 26, 2024 |
| ESMO 2023 | Conference | 15 slides | Oct 23, 2023 |
| Corporate Update (December 2022) | Corporate update | 22 slides | Dec 12, 2022 |
| Investor Presentation (January 2022) | Investor deck | 40 slides | Jan 11, 2022 |
| Investor Day (December 2021) | Investor day | 38 slides | Dec 13, 2021 |
| Corporate Update (June 2021) | Corporate update | 50 slides | Jun 4, 2021 |
| Corporate Update (December 2020) | Corporate update | 30 slides | Dec 9, 2020 |
| Technical Presentation (May 2020) | Technical | 49 slides | May 29, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Julia Marie Eastland Other companies: Zentalis Pharmaceuticals, Inc. (CEO & President, Director · Since at least Nov 13, 2024); Lantheus Holdings, Inc. (Director · Since at least Sep 3, 2024); CalciMedica, Inc. (Director · Jun 2, 2021 – Mar 23, 2023 · Past); Dynavax Technologies Corporation (Director · May 28, 2021 – May 23, 2024 · Past) | President and CEO, Director · May 4, 2021 – Mar 11, 2024 · Past |
| Natalie Sacks Other companies: Caribou Biosciences, Inc. (Partner at Novo Holdings Ventures Investment · Since at least Jul 22, 2021); Zymeworks Inc. (Director · Jan 1, 2019 – Dec 21, 2022 · Past); Aduro Biotech Inc (Chief Medical Officer · Aug 31, 2016 – Sep 12, 2018 · Past) | Chief Medical Officer · Feb 7, 2019 – Jan 28, 2022 · Past |
| Gerald PhD McMahon Other companies: Celldex Therapeutics, Inc. (Director · Dec 14, 2016 – Dec 3, 2018 · Past); Oncotelic Therapeutics Inc (Director · Sep 2, 2011 – Jun 1, 2016 · Past) | President and CEO, Director · Feb 7, 2019 – Jan 28, 2021 · Past |
| James B. Bucher Other companies: Zentalis Pharmaceuticals, Inc. (Chief Legal Officer and Corporate Secretary · Since at least Aug 26, 2025); Climb Bio, Inc. (EVP and General Counsel · Oct 31, 2022 – Oct 31, 2022 · Past) | Chief Legal Officer · Dec 21, 2023 – Mar 11, 2024 · Past |
| Lauren P. Silvernail Other companies: Dynavax Technologies Corporation (Director · Since at least Feb 3, 2025); Harrow, Inc. (Director · Since at least Jan 26, 2024) | Director · Nov 27, 2023 – Mar 11, 2024 · Past |
| Luke Walker Other companies: Context Therapeutics Inc. (Director · Since at least Sep 4, 2024); Zentalis Pharmaceuticals, Inc. (Director · Since at least May 24, 2024) | Chief Medical Officer · Oct 3, 2022 – Mar 11, 2024 · Past |
| Vijay K Lathi Other companies: iRhythm Holdings, Inc. (Director · Oct 19, 2016 – Mar 8, 2018 · Past) | Director · Mar 11, 2024 – Mar 11, 2024 · Past |
| Joseph S Bailes | Director · May 4, 2021 – Mar 11, 2024 · Past |
Log in to ask 6ix AI your own questions about Harpoon Therapeutics Inc.